Current Cancer Drug Targets
Volume 19, 11 Issues, 2019
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Ranking and Category
-
135th of 229 in
Oncology
Most Accessed Articles
Toxicology of Trastuzumab: An Insight into Mechanisms of Cardiotoxicity
, 2019; 19(5): 400-407.Jie An* and M. Saeed Sheikh*
DOI: 10.2174/1568009618666171129222159
Polyploid Giant Cancer Cells (PGCCs): The Evil Roots of Cancer
, 2019; 19(5): 360-367.Junsong Chen, Na Niu, Jing Zhang, Lisha Qi, Weiwei Shen, Krishna Vanaja Donkena, Zhenqing Feng and Jinsong Liu*
DOI: 10.2174/1568009618666180703154233
Blocking IL-6/GP130 Signaling Inhibits Cell Viability/Proliferation, Glycolysis, and Colony Forming Activity in Human Pancreatic Cancer Cells
, 2019; 19(5): 417-427.Xiang Chen, Jilai Tian, Gloria H. Su and Jiayuh Lin*
DOI: 10.2174/1568009618666180430123939
The RNA Binding Protein HuR: a Promising Drug Target for Anticancer Therapy
, 2019; 19(5): 382-399.Mingxia Wu, Christy W.S. Tong, Wei Yan, Kenneth K.W. To* and William C.S. Cho*
DOI: 10.2174/1568009618666181031145953
Targeting Glycosylation Aberrations to Improve the Efficiency of Cancer Phototherapy
, 2019; 19(5): 349-359.Guillaume Poiroux, Annick Barre, Pierre Rougé and Hervé Benoist*
DOI: 10.2174/1568009618666180628101059
Combination Therapies Using Metformin and/or Valproic Acid in Prostate Cancer: Possible Mechanistic Interactions
, 2019; 19(5): 368-381.Linh N.K. Tran*, Ganessan Kichenadasse and Pamela J. Sykes
DOI: 10.2174/1568009618666180724111604
In Silico Structure Modeling and Molecular Docking Analysis of Phosphoribosyl Pyrophosphate Amidotransferase (PPAT) with Antifolate Inhibitors
, 2019; 19(5): 408-416.Nousheen Bibi*, Zahida Parveen, Muhammad Sulaman Nawaz and Mohammad Amjad Kamal
DOI: 10.2174/1568009619666181127115015
Understanding Cancer Drug Resistance by Developing and Studying Resistant Cell Line Models
, 2016; 16(3): 226-237.Cristina P.R. Xavier, Milica Pesic and M. Helena Vasconcelos
DOI: 10.2174/1568009616666151113120705
Inhaled Micro/Nanoparticulate Anticancer Drug Formulations: An Emerging Targeted Drug Delivery Strategy for Lung Cancers
, 2019; 19(3): 162-178.Nazrul Islam* and Derek Richard
DOI: 10.2174/1568009618666180525083451
Efficacy and Safety of Antigen-specific Immunotherapy in the Treatment of Patients with Non-small-cell Lung Cancer: A Systematic Review and Meta-analysis
, 2019; 19(3): 199-209.Bing-Di Yan, Xiao-Feng Cong, Sha-Sha Zhao, Meng Ren, Zi-Ling Liu, Zhi Li, Chen Chen and Lei Yang*
DOI: 10.2174/1568009618666180430124738
  |
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA
View Full Editorial Board
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA
View Full Editorial Board
About the Journal
For Authors
For Librarians & Readers
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net